2021
18 March, 2021
FluoGuide appoints new Certified Adviser
FluoGuide appoints Svensk Kapitalmarknadsgransking AB (SKMG), as its new Certified Adviser (CA), from 1. April 2021. Västra Hamnen...
Photothermal therapy is an extension of photodynamic therapy, in which a photosensitizer (e.g. FG001) is excited with light of a specific...
17 February, 2021
FluoGuide gets green light to proceed to fourth dose level with FG001 in the ongoing clinical phase I/II trial in patients with high grade glioma
Evaluation of the results from the third dose level of FG001, including data from three patients, have been finalized and reported...
9 February, 2021
Minutes from the Annual General Meeting in FluoGuide A/S
The agenda for the general meeting was as follows: Henrik Moltke, CFO was elected chairman of the meeting. The chairman ascertained...
5 February, 2021
FluoGuide announces approval for listing on Nasdaq First North Growth Market Sweden on the 24 February 2021
FluoGuide has applied for and received approval for admission to trading on Nasdaq First North. The first day of trading in the Company’s...
3 February, 2021
FluoGuide plans to change listing venue from Spotlight to Nasdaq First North Sweden and publishes Company Description
FluoGuide has advanced rapidly since its IPO. The change of listing venue is a natural consequence of this. It will also provide optimal...
2 February, 2021
FluoGuide annonces publication of two patent applications covering the company’s uPAR technology platform for improving surgery
FluoGuide hereby updates on the status of its published patents and patent applications. Since prior to the IPO, FluoGuide holds the...
26 January, 2021
FluoGuide A/S publishes annual report for the fiscal year 2020
Fourth quarter 2020 (1 October – 31 December): Full year 2020 (1 January – 31 December): *) Result per share (DKK per share)...
26 January, 2021
FluoGuide A/S publishes Year-end report for 2020
Fourth quarter 2020 (1 October – 31 December): Full year 2020 (1 January – 31 December): *) Result per share (DKK per share)...